fucose has been researched along with HIV Coinfection in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Anderluh, M; Fieschi, F; Hajšek, D; Luzar, J; Obermajer, N; Petit-Haertlein, I; Švajger, U; Tomašić, T | 1 |
Abdel-Mohsen, M; George, AF; Giron, L; Ma, T; McGregor, M; Roan, NR; Xie, G | 1 |
Abdel-Mohsen, M; Adeniji, OS; Battivelli, E; Betts, MR; Colomb, F; Dweep, H; Giron, LB; Kossenkov, AV; Kuri-Cervantes, L; Ma, T; Palmer, CS; Roan, NR; Tateno, H; Verdin, E | 1 |
Alter, G; Joosten, SA; Ottenhoff, THM | 1 |
Andreini, M; Belvisi, L; Bernardi, A; Chabrol, E; Doknic, D; Doro, F; Duan, J; Fieschi, F; Moroni, E; Reina, JJ; Rojo, J; Sutkeviciute, I; Thepaut, M; Weiser, J | 1 |
Bélec, L; Magri, G; Nasreddine, N; Réquena, M; Saïdi, H | 1 |
1 review(s) available for fucose and HIV Coinfection
Article | Year |
---|---|
Antibody glycosylation in inflammation, disease and vaccination.
Topics: Aging; Antibodies; Antigens; Carbohydrate Sequence; Fucose; Galactose; Glycosylation; HIV Infections; Humans; Immunoglobulin G; Inflammation; Influenza, Human; Protein Processing, Post-Translational; Sialic Acids; Vaccination; Viral Vaccines | 2018 |
5 other study(ies) available for fucose and HIV Coinfection
Article | Year |
---|---|
Monovalent mannose-based DC-SIGN antagonists: targeting the hydrophobic groove of the receptor.
Topics: Binding Sites; Cell Adhesion Molecules; Dendritic Cells; HIV Envelope Protein gp120; HIV Infections; HIV-1; Host-Pathogen Interactions; Humans; Lectins, C-Type; Mannose; Molecular Docking Simulation; Receptors, Cell Surface | 2014 |
Single-cell glycomics analysis by CyTOF-Lec reveals glycan features defining cells differentially susceptible to HIV.
Topics: CD4-Positive T-Lymphocytes; Disease Susceptibility; Fucose; Glycomics; HIV Infections; HIV-1; Humans; N-Acetylneuraminic Acid; Polysaccharides | 2022 |
Sialyl-Lewis
Topics: Antiretroviral Therapy, Highly Active; Carbohydrates; CD4-Positive T-Lymphocytes; Cell Line; Cell Membrane; Fucose; Glycomics; Glycosylation; HIV; HIV Infections; Humans; Immunologic Memory; Ligands; Lymphocyte Activation; Sialyl Lewis X Antigen; Transcription, Genetic | 2020 |
Second generation of fucose-based DC-SIGN ligands: affinity improvement and specificity versus Langerin.
Topics: Anti-HIV Agents; Antigens, CD; Cell Adhesion Molecules; Fucose; HIV Infections; Humans; Lectins, C-Type; Mannose-Binding Lectins; Models, Molecular; Protein Binding; Receptors, Cell Surface | 2011 |
R5- and X4-HIV-1 use differentially the endometrial epithelial cells HEC-1A to ensure their own spread: implication for mechanisms of sexual transmission.
Topics: Acetylglucosamine; Anti-HIV Agents; CCR5 Receptor Antagonists; Cell Line; Chemokine CXCL1; Chemokines, CXC; Endocytosis; Endometrium; Epithelial Cells; Female; Fucose; Heparan Sulfate Proteoglycans; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Interleukin-1alpha; Interleukin-8; Lectins, C-Type; Mannose; Mannose Receptor; Mannose-Binding Lectins; Receptors, CCR5; Receptors, Cell Surface; Receptors, CXCR4; Tumor Necrosis Factor-alpha; Virulence; Virus Attachment | 2007 |